Skip to main content
logo
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
3.930
-0.080 (-2.00%)
Oct 26, 2026, 2:32 PM EDT - Market open

Vanda Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-274.85-220.47-18.92.516.2833.15
Depreciation & Amortization
13.4311.929.84.332.732.84
Loss (Gain) From Sale of Investments
-0.93-2.05-6.99-8.14-2.961.64
Stock-Based Compensation
9.079.4712.4314.0416.2815.37
Other Operating Activities
98.7583.39-5.540.813.598.47
Change in Accounts Receivable
-14.78-7.46-13.01-0.71-1.09-2.47
Change in Inventory
-1.05-3.47-0.03-0.77-4.48-2.23
Change in Accounts Payable
10.5415.821.71-10.9811.793.04
Change in Other Net Operating Assets
17.493.424.7811.72-0.154.4
Operating Cash Flow
-142.33-109.44-15.7612.831.9864.21
Operating Cash Flow Growth
----59.98%-50.19%24.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.67-1-4.72-101.05-0.68-0.55
Sale (Purchase) of Intangibles
-10-----
Investment in Securities
130.9595.86-12.7188.9950.6-76.14
Investing Cash Flow
120.2794.86-17.43-12.0649.93-76.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--1.99-0.16---
Net Debt Issued (Repaid)
-2.79-1.99-0.16---
Issuance of Common Stock
----0.733.55
Repurchase of Common Stock
--0.92----
Financing Cash Flow
-2.79-2.91-0.16-0.733.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.250.02-0.160.050.27-0.09
Net Cash Flow
-25.1-17.47-33.510.7982.91-9.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-143.01-110.44-20.48-88.2531.3163.66
Free Cash Flow Growth
-----50.83%27.38%
Free Cash Flow Margin
-66.29%-51.11%-10.30%-45.81%12.31%23.69%
Free Cash Flow Per Share
-2.40-1.87-0.35-1.530.551.12
Levered Free Cash Flow
-86.72-49.36-17.05-87.4532.3448.22
Unlevered Free Cash Flow
-86.72-49.36-17.05-87.4532.3448.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--0.092.453.56--
Change in Working Capital
12.28.31-6.56-0.756.072.74
SEC Filings: 10-K · 10-Q